医学
肾病
期限(时间)
中国
梅德林
重症监护医学
免疫学
内分泌学
糖尿病
物理
量子力学
政治学
法学
作者
Xue Shen,Pei‐Jer Chen,Muqing Liu,Lijun Liu,Sufang Shi,Shu‐Feng Zhou,Jicheng Lv,Hong Zhang
摘要
The long-term outcomes for patients with IgAN under current treatment strategies remain poor, with most progressing to ESKD within 15 years. Patients with time-averaged proteinuria ≥0.5 g/day experience worse kidney outcomes, challenging the previous view that proteinuria <1.0 g/day was associated with a low risk of kidney failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI